HC Wainwright Reiterates Buy on Connect Biopharma, $7 Target
HC Wainwright & Co. reiterated a Buy rating on Connect Biopharma Hldgs with a price target of $7.00, implying a 614.5% upside from the Oct. 1 close of $0.98.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
HC Wainwright reiterates Buy on Connect Biopharma, $7 target
HC Wainwright & Co. reiterated a Buy rating on Connect Biopharma Holdings and set a $7.00 price target.